References
- Hakuba N, Gyo K, Yanagihara N, Mitani A, Kataoka K. Efflux of glutamate into the perilymph of the cochlea following transient ischemia in the gerbil. Neurosci Lett 1997;230:69–71.
- Hakuba N, Koga K, Shudou M, Watanabe F, Mitani A, Gyo K. Hearing loss and glutamate efflux in the perilymph following transient hindbrain ischemia in gerbils. J Comp Neurol 2000;418:217–26.
- Fujiwara T, Hato N, Nakagawa T, Tabata Y, Yoshida T, Komobuchi H, et al. Insulin-like growth factor 1 treatment via hydrogels rescues cochlear hair cells from ischemic injury. Neuroreport 2008;19:1585–8.
- Sano A, Hineno T, Mizuno T, Kondoh K, Ueno S, Kakimoto Y, et al. Sphingolipid hydrolase activator proteins and their precursors. Biochem Biophys Res Commun 1989;165:1191–7.
- Harzer K. Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidases. Eur J Pediatr 1989;149:31–9.
- Fujita N, Suzuki K, Vanier MT, Popko B, Maeda N, Klein A, et al. Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids. Hum Mol Genet 1996;5:711–25.
- O'Brien JS, Carson GS, Seo HC, Hiraiwa M, Kishimoto Y. Identification of prosaposin as a neurotrophic factor. Proc Natl Acad Sci USA 1994;91:9593–6.
- Kotani Y, Matsuda S, Wen TC, Sakanaka M, Tanaka J, Maeda N, et al. A hydrophilic peptide comprising 18 amino acid residues of the prosaposin sequence has neurotrophic activity in vitro and in vivo. J Neurochem 1996;66:2197–200.
- Sano A, Matsuda S, Wen TC, Kotani Y, Kondoh K, Ueno S, et al. Protection by prosaposin against ischemia-induced learning disability and neuronal loss. Biochem Biophys Res Commun 1994;204:994–1000.
- Kotani Y, Matsuda S, Sakanaka M, Kondoh K, Ueno S, Sano A. Prosaposin facilitates sciatic nerve regeneration in vivo. J Neurochem 1996;66:2019–25.
- Akil O, Lustig LR. Severe vestibular dysfunction and altered vestibular innervation in mice lacking prosaposin. Neurosci Res 2012;72:296–305.
- Hata R, Matsumoto M, Hatakeyama T, Ohtsuki T, Handa N, Niinobe M, et al. Differential vulnerability in the hindbrain neurons and local cerebral blood flow during bilateral vertebral occlusion in gerbils. Neuroscience 1993;56:423–39.
- Terashita T, Saito S, Miyawaki K, Hyodo M, Kobayashi N, Shimokawa T, et al. Localization of prosaposin in rat cochlea. Neurosci Res 2007;57:372–8.
- Calcutt NA, Freshwater JD, O'Brien JS. Protection of sensory function and antihyperalgesic properties of a prosaposin-derived peptide in diabetic rats. Anesthesiology 2000;93:1271–8.
- Hiwaiwa M, Taylor EM, Campana WM, Darin SJ, O'Brien JS. Cell death prevention, mitogen-activated protein kinase stimulation, and increased sulfatide concentrations in Schwann cells and oligodendrocytes by prosaposin and prosaptides. Proc Natl Acad Sci USA 1997;94:4778–81.
- Rusznák Z, Szücs G. Spiral ganglion neurons: an overview of morphology, firing behaviour, ionic channels and functions. Pflugers Arch 2009;457:1303–25.
- Martindale JL, Holbrook NJ. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 2002;192:1–15.
- Hiesberger T, Huttler S, Rohlmann A, Schneider W, Sandoff K, Herz J. Cellular uptake of saposin (SAP) precursor and lysosomal delivery by the low density lipoprotein receptor-related protein (LRP). EMBO J 1998;17:4617–25.
- Campana WM, Hiraiwa M, Addison KC, O'Brien JS. Induction of MAPK phosphorylation by prosaposin and prosaptide in PC 12 cells. Biochem Biophys Res Commun 1996;229:706–12.
- Ochiai T, Takenaka Y, Kuramoto Y, Kasuya M, Fukuda K, Kimura M, et al. Molecular mechanism for neuro-protective effect of prosaposin against oxidative stress: its regulation of dimeric transcription factor formation. Biochim Biophys Acta 2008;1780:1441–7.